Skip to main content

Table 4 CVD and CKD risk factors at baseline (Prescribed Patient Set)

From: Real-world characteristics, modern antidiabetic treatment patterns, and comorbidities of patients with type 2 diabetes in central and Eastern Europe: retrospective cross-sectional and longitudinal evaluations in the CORDIALLY® study

HCP specialty

Endocrinologist

Diabetologist

Cardiologist

Study medication and characteristic

Empa

N = 815

DPP4i

N = 504

GLP-1 RA

N = 89

Other SGLT2i

N = 244

Total

N = 1652

Empa

N = 1073

DPP4i

N = 624

GLP-1 RA

N = 271

Other SGLT2i

N = 333

Total

N = 2301

Empa

N = 78

DPP4i

N = 16

GLP-1 RA

N = 1

Other SGLT2i

N = 7

Total

N = 102

(A) Categorically assessed CVD and CKD risk factors

 BMI (%)

  Overweight

25.6

36.5

11.2

18.9

27.2

23.4

37.2

10.7

25.5

25.9

37.2

43.8

100

42.9

39.2

  Obese

72.0

56.0

87.6

78.3

68.9

72.2

51.9

86.3

68.8

67.9

55.1

50

0

57.1

53.9

 Hypertension (%)

87.5

83.7

85.4

83.2

85.6

85.6

80.0

85.6

82.6

83.7

89.7

100

100

85.7

91.2

  Unknown

0.4

0.2

0

0.4

0.3

1.1

1.6

1.8

0.6

1.3

0

0

0

0

0

 Never smoked (%)

52.9

66.3

52.8

58.2

57.7

43.7

54.2

56.1

48.0

48.6

46.2

50

100

71.4

49.0

  Unknown

4.8

4.8

4.5

7.0

5.1

13.4

9.6

6.3

8.4

10.8

1.3

6.3

0

0

2.0

 Physically inactive (%)*

57.4

52.6

59.6

50.4

55.0

43.1

48.1

50.6

54.7

47

50.0

93.8

100

57.1

56.9

  Unknown

5.0

10.1

4.5

9.4

7.2

7.5

6.9

5.9

3.3

6.5

1.2

0

0

14.3

2.0

Family history (%)

  Early onset heart disease

37.6

29.4

39.3

32

34.3

25.7

18.1

23.3

22.2

22.9

46.2

18.8

0

0

38.2

   Unknown

18.5

27.2

18.0

22.1

21.7

27.0

23.7

25.5

31.8

26.6

6.4

6.3

0

14.3

6.9

  Early onset kidney disease

8.1

7.3

4.5

4.9

7.2

6.9

4.2

4.8

7.2

6.0

11.5

6.3

0

0

9.8

  Unknown

22.8

31.9

18.0

27.9

26.1

34.6

27.4

27.3

36.9

32.1

10.3

6.3

0

14.3

9.8

(B) Ten-year fatal CVD risk (SCORE Risk Chart)

 10 year fatal CVD risk, mean (SD)

6.4 (5.7)

5.6 (4.7)

4.3 (3.7)

6.0 (5.7)

6.0 (5.3)

7.0 (5.5)

7.0 (5.9)

5.4 (4.7)

6.5 (5.1)

6.7 (5.5)

8.9 (7.7)

9.4 (7.8)

5.0

3.8 (2.3)

8.6 (7.5)

  Missing (%)

24.5

20.0

30.3

26.6

23.8

43.2

43.1

42.8

50.8

44.2

30.8

31.3

0

28.6

30.4

  1. BMI body mass index, CKD chronic kidney disease, CVD cardiovascular disease, DPP4i dipeptidyl peptidase-4 inhibitor, Empa empagliflozin, GLP-1 RA glucagon-like peptide-1 receptor agonist, HCP healthcare professional, SD standard deviation, SGLT2i sodium-glucose cotransporter-2 inhibitor, T2D type 2 diabetes
  2. *Less than 2.5 h of moderate or 75 min of vigorous aerobic exercise per week